Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1241-1243

  Marsh, Debbie J ^a,b   Andrew, Scott D ^a   Eng, Charis ^c,d   Learoyd, Diana L ^a,b   Capes, Amanda G ^a,b   Pojer, Ruth ^a   Richardson, Ann Louise ^a   Houghton, Carol ^d   Mulligan, Lois M ^e   Ponder, Bruce A J ^d   Robinson, Bruce G ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; FAMILIAL CANCER; GENE MUTATION; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; PRIORITY JOURNAL; PROTO ONCOGENE; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

CARCINOMA, MEDULLARY; CODON; EXONS; FAMILY HEALTH; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; POINT MUTATION; PROTO-ONCOGENES; THYROID NEOPLASMS;

EID: 13344270364     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mulligan, L M., Kwok, J B , Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K , Papi, L., Ponder, M. A., Telenius, H., Tunnacliffe, A., and Ponder, B. A. J. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (Lond.), 363: 458-460, 1993.
2. Donis Keller, H., Dou, S , Chi, D , Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F , Goodfellow, P., and Wells, S. A. J. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol. Genet., 2: 851-856, 1993
3. Eng, C., Smith, D. P , Mulligan, L. M., Nagai, M A., Healey, C. S., Ponder, M A., Gardner, E., Scheumann, G F., Jackson, C E , Tunnacliffe, A., and Ponder, B A. J. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet., 3: 237-241, 1994.
4. Carlson, K. M., Dou, S., Chi, D., Scavarda, N., Toshima, K., Jackson, C. E., Wells, S. A., Jr., Goodfellow, P. J., and Donis Keller, H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B Proc. Natl. Acad. Sci. USA, 91: 1579-1583, 1994.
5. Hofstra, R. M , Landsvater, R. M., Ceccherini, I., Stulp, R P., Stelwagen, T , Luo, Y., Pasini, B., Hoppener, J. W., van Amstel, H. K., Romeo, G , Lips, C. J. M., and Buys, C. H. C. M. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature (Lond ), 367: 375-376, 1994
6. Asai, N., Iwashita, T., Matsuyama, M., and Tikahashi, M. Mechanism of Activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell. Biol., 15: 1613-1619, 1995.
7. Bolino, A , Schuffenecker, I , Luo, Y., Seri, M., Silengo, M . Tocco, T , Chabner, G , Houdent, C., Murat, A , Schlumberger, M., Tourniaire, J., Lenoir, G. M , and Romeo, G. RET mutations in exons 13 and 14 of FMTC patients. Oncogene, 10. 2415-2419, 1995.
8. Eng, C., Smith, D. P., Mulligan, L. M., Healey, C. S., Zvelebil, M. J., Stonehouse, T. J., Ponder, M. A., Jackson, C. E., Waterfield, M. D., and Ponder, B. A J. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene, 10: 509-513, 1995.
9. Santoro, M., Carlomagno, F., Romano, A., Bottaro, D P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., and di Fiore, P P. Activation of RET 25 a dominant transforming gene by germline mutations of MEN 2 A and MEN 2B. Science (Washington DC), 267: 381-383, 1995
10. Zedenius, J., Wallin, G , Hamberger, B., Nordenskjold, M , Weber, G., and Larssoa, C. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTCs Hum. Mol Genet., 3. 1259-1262, 1994
11. Blaugrund, J. E., Johns, M M , Eby, Y. J., Ball, D. W , Baylin, S. B., Hruban, R H , and Sidransky, D. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum. Mol. Genet., 3: 1895-1897, 1994.
12. Eng, C., Mulligan, L. M., Smith, D. P , Healey, C. S , Frilling, A., Raue, F., Neumann, H. P H., Pfragner, R., Behmel, A., Lorenzo, M. J., Stonehouse, T. J., Ponder, M A., and Pander, B. A. J. Mutation of the RET proto-oncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes & Cancer, 12: 209-212, 1995.
13. Dou, C., Chi, D., Carlson, K. M., Moley, J. A., Wells, S. A., and Donis-Keller, H. RET proto-oncogene mutations associated with sporadic cases of medullary thyroid carcinoma. Proceedings of the Fifth International Workshop on Multiple Endocrine Neoplasia, p. 73, 1994.
14. Songyang, Z , Carraway, K. L., Eck, M J., Harrison, S. C , Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., Lorenzo, M. J., Ponder, B. A J., Mayer, B. J., and Cantley, L. C. Catalytic specificity of protein tyrosine kinases is critical for selective signalling. Nature (Lond.), 373: 536-539, 1995.
15. Knudson, A. G. Antioncogenes and human cancer Proc. Natl Acad. Sci. USA, 90: 10914-10921, 1993.
16. Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.
17. Ichii, S., Horii, A., Nakatsuru, S., Furuyama, J., Utsunomiya, J., and Nakamura, Y. Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP). Hum. Mol. Genet., 1. 387-390, 1992.
18. Kato, M. V., Ishizaki, K., Shimizu, T., Ejima, Y., Tanooka, H , Takayama, J., Kaneko, A., Toguchida, J., and Sasaki, M. S. Parental origin of germ-line and somatic mutations in the retinoblastoma gene. Hum. Genet., 94: 31-38, 1994.
19. Wolfe, H. J., Melvin, K. E. W., Cervi-Skinner, S. J., Al Saadi, A. A., Juliar, J. F., Jackson, C. E., and Tashjian, A H C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl. J. Med , 289. 437-441, 1973.
20. Graze, K., Spiler, I. J , Tashjian, A. H , Jr., Melvin, K. E., Cervi Skinner, S., Gagel, R. F., Miller, H. H., Wolfe, H. J., DeLellis, R. A., Leape, L., Feldman, Z. T., and Reichlin, S. Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis N. Engl J. Med , 299: 980-985, 1978.
21. Marsh, D J., Robinson, B G., Andrew, S , Richardson, A. L., Pojer, R., Schnitzler, M , Mulligan, L. M , and Hyland, V. J. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. Genomics, 23: 477-479, 1994.
22. Mulligan, L M., Eng, C., Healey, C. S., Clayton, D., Kwok, J. B., Gardner, E., Ponder, M. A , Frilling, A., Jackson, C. E., Lehnert, H., Neumann, H. P. H , Thibodeau, S. N., and Ponder, B. A. J. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat. Genet. 6: 70-74, 1994.
23. Mulligan, L. M., Marsh, D. J., Robinson, B. G., Schuffenecker, I , Zedenius, J., Lips, C. J M., Gagel, R. F., Takaj, S. I., Noll, W. W., Niederle, B., Raue, F., Lacroix, A., Thibodeau, S. N , Frilling, A , Ponder, B. A J., and Eng, C. International RET mutation consortium genotype-phenotype correlation in MEN 2, report of the international RET mutation consortium. J. Intern. Med., 238: 343-346, 1995.
24. Ward, J. L., Hyland, V. J., Andrew, D S , Marsh, D. J., and Robinson, B. G Medullary thyroid carcinoma: Australian experience with genetic testing Henry Ford Hosp Med J , 40. 220-223, 1992.
25. Mathew, C G., Chin, K. S., Easton, D. F., Thorpe, K., Carter, C., Liou, G I., Fong, S L., Bridges, C D., Haak, H., Kruseman, A. C., Schifter, S., Hansen, H. H , Telenius, H , Telenius-Berg, M , and Ponder, B. A. J A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature (Lond.), 328: 527-528, 1987
26. Wright, D K , and Manos, M Sample preparation from paraffin-embedded tissues. In: M. A. Innis, D. H. Gelfand, J J. Sninsky, and T J White (eds.), PCR Protocols: A Guide to Methods and Application, pp 153-158. San Diego: Harcourt Brace Jovanovich, 1990.
27. Mulligan, L. M., Eng, C., Attie, T., Lyonnet, S , Marsh, D. J., Hyland, V. J., Robinson, B. G., Frilling, A., Verellen-Dumoulin, C , Safar, A , Munnich, A , and Ponder, B. A. J Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum. Mol Genet., 3: 2163-2167, 1994.
28. Marsh, D J., Learoyd, D. L , Andrew, S D., Krishnan, L., Pojer, R , Richardson, A. L., Delbridge, L., Eng, C., and Robinson, B. G. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin. Endocrinol., in press, 1996.
29. Heldin, C H Dimerisation of cell surface receptors in signal transduction. Cell, 80: 213-223, 1995
30. Mulligan, L M , Gardner, E., Smith, B A., Mathew, C. G P , and Ponder, B A. J. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2 Genes Chromosomes & Cancer. 6. 166-177, 1993